In BPH, we detected immunoreactions to c-IAP-1/2, c-IAP-2, ILP-2, NAIP, survivin, XIAP, p-Elk-1, p-ATF-2 and NF-kB (p50 and p65). This evidence concerns the gene ELK1 and benign prostatic hyperplasia.